Nektar Therapeutics (NKTR, $22.82) was one of top quarterly gainers, jumping +40.26% to $22.82 per share. My A.I.dvisor analyzed 169 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that 156 of them (92.52%) charted an Uptrend while 13 of them (7.48%) trended down.My A.I.dvisor found 426 similar cases when NKTR's price went up 15% within three months. In 218 out of those 426 cases, NKTR's price went down during the following month. Based on these historical data, my A.I. thinks the odds of an Uptrend reversal for NKTR are 51%.